Positive Results for Patisiran in ATTR Amyloidosis Cardiomyopathy ...Middle East

Medscape - News
The RNAi therapeutic patisiran improves functional capacity and quality of life in ATTR amyloidosis with cardiomyopathy, topline results of APOLLO-B show. The company will seek an FDA supplemental NDA. Medscape Medical News

Hence then, the article about positive results for patisiran in attr amyloidosis cardiomyopathy was published today ( ) and is available on Medscape ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Positive Results for Patisiran in ATTR Amyloidosis Cardiomyopathy )

Apple Storegoogle play

Last updated :

Also on site :

Most viewed in News